SELLAS Life Sciences Group, Inc. Quarterly Costs and Expenses in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
SELLAS Life Sciences Group, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2013 to Q3 2024.
  • SELLAS Life Sciences Group, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $7.33M, a 21.7% decline year-over-year.
  • SELLAS Life Sciences Group, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $32.8M, a 16.3% decline year-over-year.
  • SELLAS Life Sciences Group, Inc. annual Costs and Expenses for 2023 was $37.9M, a 11.8% decline from 2022.
  • SELLAS Life Sciences Group, Inc. annual Costs and Expenses for 2022 was $43M, a 30.6% increase from 2021.
  • SELLAS Life Sciences Group, Inc. annual Costs and Expenses for 2021 was $32.9M, a 74.2% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $32.8M $7.33M -$2.03M -21.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $34.8M $7.62M -$1.43M -15.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $36.2M $9.65M -$1.64M -14.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $37.9M $8.18M -$1.27M -13.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $39.1M $9.36M +$2.22M +31% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $36.9M $9.05M +$427K +4.95% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $36.5M $11.3M -$6.45M -36.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $43M $9.45M -$2.17M -18.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $45.1M $7.15M +$169K +2.42% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $45M $8.62M +$2.27M +35.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $42.7M $17.7M +$9.79M +123% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $32.9M $11.6M +$5.56M +91.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $27.3M $6.98M +$2.49M +55.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $24.8M $6.35M +$2.09M +48.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $22.8M $7.95M +$3.88M +95.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $18.9M $6.06M -$1.42M -19% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $20.3M $4.49M +$308K +7.36% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $20M $4.27M +$248K +6.17% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $19.7M $4.06M -$295K -6.77% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $20M $7.48M -$8.36M -52.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-23
Q3 2019 $28.4M $4.18M +$1.12M +36.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $27.3M $4.02M -$2.48M -38.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $29.8M $4.36M -$1.33M -23.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $31.1M $15.8M +$7.23M +84% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 $23.9M $3.06M -$1.23M -28.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $25.1M $6.5M +$833K +14.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $24.3M $5.68M +$1.21M +27.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $23M $8.61M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-22
Q3 2017 $4.29M -$2.18M -33.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $5.67M -$3.62M -39% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $4.47M -$4.5M -50.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q3 2016 $6.47M -$2.16M -25% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $9.29M +$209K +2.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $8.97M +$56K +0.63% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q3 2015 $8.64M -$1.93M -18.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $9.08M -$9.03M -49.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $8.91M -$5.11M -36.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q3 2014 $10.6M +$2.5M +31.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $18.1M +$10.1M +127% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $14M +$7.41M +112% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q3 2013 $8.06M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 $7.99M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $6.61M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.